Introduction
Several new methods have been developed for screening drug-resistant strains of Mycobacterium tuberculosis, 1-3 but these methods can only be applied to clinical isolates from clinical specimens. Genes that confer drug-resistance of M. tuberculosis are gradually being identified, and gene mutations in mycobacteria that confer resistance to isoniazid and rifampicin have already been identified. A relationship between MIC and type of rpoB gene mutation in rifampicin-resistant strains of M. tuberculosis has also been reported. 4, 5 We evaluated here the relationship between genetic alterations in rpsL and MICs of streptomycin in a large number of M. tuberculosis strains isolated from Japanese patients. We also compared two methods, namely direct DNA sequence analysis and restriction fragment length polymorphism (RFLP) analysis, for their ability to detect mutations in rpsL in streptomycinresistant M. tuberculosis strains.
Materials and methods
We used 121 clinical isolates of M. tuberculosis. Resistance to one or more antituberculous drugs was based on the clinical course and/or results of susceptibility tests. We also used an M. tuberculosis standard strain, H37Rv, as a control. Susceptibility tests were performed by a broth microdilution method. 4 A few colonies of M. tuberculosis, grown on Ogawa egg-based medium, were inoculated into 15 mL ADC-supplemented Middlebrook 7H9 broth (Difco, Detroit, MI, USA) and cultured at 37°C for 1 week. The concentration of bacteria was adjusted to that of a McFarland 0.5 standard (≈10 6 cfu/mL). One hundred microlitres of a solution of streptomycin (Meiji Seika Co., Tokyo, Japan) in Middlebrook 7H9 broth containing ADC supplement was dispensed into each well of a 96-well microplate (Corning Glass Works, New York, NY, USA). The concentration of streptomycin ranged from 0.5 to 4096 mg/L. Plates were stored at -70°C until use. Each well was inoculated with 100 L of bacterial suspension (10 6 cfu/mL) and cultured in a plastic container. The final concentration of streptomycin in the wells ranged from 0.25 to 2048 mg/L. When growth was observed in streptomycin-free wells, the MIC was taken as the lowest concentration of streptomycin resulting in absence of visible mycobacterial growth. After incubation for 21 days the MICs were determined again to exclude falsely susceptible strains. A nitrate reduction assay was also performed to confirm the presence or absence of bacterial growth.
DNA was extracted from a few colonies that had been grown on Ogawa egg-based medium using the phenol/ chloroform method. 4, 5 Ten nanograms of each DNA was used for specific PCR of M. tuberculosis targeting protein antigen b (pab) gene. 4 
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in a 2% agarose gel (Seakem ME agarose, FMC BioProducts, Rockland, ME, USA), stained with ethidium bromide, and visualized by UV transillumination. We designed two primers, based on the sequence of the rpsL gene which encodes the M. tuberculosis ribosomal protein S12, 6 to amplify a 360 bp internal fragment of rpsL. These primers, 5 -ATGCCAACCATCCAGCAGCT-3 and 5 -CTTAGCGCCGTAACGGCTGC-3 , were synthesized using a Model 380B DNA synthesizer (Applied Biosystems, Foster City, CA, USA). Amplification was performed by using a Perkin-Elmer 9600 DNA Thermal Cycler (Perkin-Elmer Medical Instruments, Pomona, CA, USA). All PCR reactions comprised 40 cycles of 1 min at 94°C for denaturation, 1 min at 60°C for annealing and 1 min at 72°C for extension. After the final cycle, samples were maintained at 4°C until analysis. PCR products were electrophoresed in 2% agarose gel and confirmed by ethidium bromide staining as described above. The presence or absence of amplicons representing the 419 bp fragment of pab and the 360 bp fragment of rpsL was determined.
We used two methods for detecting streptomycin-resistant strains based on analysis of the rpsL gene: direct DNA sequencing and RFLP analysis using a restriction enzyme. For the former method, 10 ng of M. tuberculosis DNA was used. Sequencing was performed using the ABI PRISM Ready Reaction DyeDeoxy Terminator Cycle Sequencing FS kit (Perkin-Elmer). The reaction mixture was prepared as follows: 1.5 L PCR templates were purified using Suprec 02 (Takara Shuzo Co., Shiga, Japan), 3.2 pmol primer, 4 L 5 Terminator Ammonium Cycle Sequencing buffer, 1 L dNTP, 1 L DyeDeoxy terminator which labels each of the four different bases, and 4 U Taq polymerase. The sequencing reaction was performed on both strands, using the following primers: 5 -ATGCCAAC-CATCCAGCAGCT-3 and 5 -CTTAGCGCCGTAAC-GGCTGC-3 . The reaction mixture was subjected to 25 cycles of 15 s at 96°C for denaturation, 5 s at 50°C for annealing, and 4 min at 60°C for extension. Then 74 L of 70% ethanol was added to the PCR samples before they were incubated on ice for 30 min and centrifuged at 10,000g for 20 min. The supernatant was discarded and the precipitate was dried in a Speed-vac for 5 min, resuspended in 6 L of loading buffer (5:1 ratio of deionized formamide: 25 mM EDTA) and denatured at 90°C for 2 min before loading on to a 5% Long Ranger gel (Takara Shuzo Co.). Reactions were analysed using an ABI PRISM 377 DNA sequencer (Applied Biosystems).
For rapid detection of mutations at codon 43, RFLP analysis was used with the restriction enzyme MboII. For this purpose, 1 g of PCR product, 10 U of MboII, 5 L of a reaction buffer (10 mM Tris-HCl, 10 mM MgCl 2 , 1 mM dithiothreitol, pH 7.5), and 24 L deionized distilled water were placed into a new microcentrifuge tube and mixed. The reaction was allowed to proceed for 1 h at 37°C, and was then electrophoresed in a 3% agarose gel (Nusieve 3:1 agarose, FMC BioProducts) and stained with ethidium bromide. The patterns of DNA bands were compared with those of the control H37Rv strain.
Results
All 121 strains of M. tuberculosis were positive for the amplification of pab and rpsL, confirming that they were M. tuberculosis 4 (data not shown). The relationship between MICs of streptomycin against 121 strains and the position and type of genetic alteration in the rpsL gene are shown in the Table. The presence of bacterial growth at streptomycin concentrations 10 mg/L was considered as an index of streptomycin resistance in liquid medium; using this criterion, 49 (41%) of the 121 isolates were streptomycin resistant. A total of 23 genetic alterations were detected in the 121 strains examined, with mutations being detected in 47% of the resistant strains. No alteration was observed in the remaining 98 strains and double point mutations were not present in any strain. Mutations at codon 43 (AAG AGG; resulting in Lys Arg amino acid substitution) were found in 18 of the 121 strains; mutations at codon 88 were found in five strains, of which four had a Lys Arg (AAG AGG) change and the other had a Lys Gln (AAG CAG) change. Thus 78% of the substitutions detected were in codon 43 and 22% in codon 88. The MICs of streptomycin for all these 23 strains containing a point mutation were 256 mg/L, except for one streptomycin-resistant strain with mutation at codon 88 (Lys Arg) with an MIC of 16 mg/L. In 98 strains with no genetic alterations, 72 (74%) of strains had a streptomycinsusceptible phenotype with MICs 10 mg/L, but the remaining 26 strains were streptomycin-resistant.
Results of the RFLP analysis of the rpsL gene are shown in the Figure. Two types of RFLP pattern were observed. The 360 bp amplified products from the rpsL gene were digested by MboII into two fragments, of 138 bp and 222 bp, in 103 strains and in the H37Rv strain without mutation at codon 43. In the remaining 18 strains, which had a mutation at codon 43 and were resistant to streptomycin (MICs 256 mg/L), the 360 bp product was not digested by MboII.
Discussion
Our results showed that almost all of the highly streptomycin-resistant strains (MICs 256 mg/L) had an alteration in the rpsL gene. The mutations detected were all in either codon 43 (Lys Arg) or codon 88 (Lys Arg, or Lys Gln). Thus, all strains with point mutations in codons 43 or 88 were streptomycin resistant, consistent with other reports. [6] [7] [8] [9] [10] Our results also showed that RFLP analysis using MboII was useful in detecting certain point mutations at codon 43. Although direct sequencing is necessary for detailed information on the nature of the point mutation, our RFLP test is cost-effective and faster. Therefore, we propose that RFLP analysis is a useful screening test for detecting highly streptomycin-resistant strains, particularly when analysing a large number of clinical samples.
In addition to rpsL, the rrs gene (which encodes 16S ribosomal RNA) has been implicated in streptomycin resistance with a frequency of about 10%. [6] [7] [8] [9] Recent studies have also shown that low-level streptomycin resistance (MIC 10 mg/L) is determined by different genes from high-level streptomycin resistance (MIC 160 mg/L). 8, 10 All 23 highly resistant strains with point mutations in rpsL were quickly detected in our study. However, 26 resistant strains without genetic alterations could not be predicted by such a molecular technique. Further studies are necessary to identify additional mechanisms conferring streptomycin resistance. Such studies should be extended to the development of new methods for detecting streptomycinresistance genes directly from clinical specimens. The E. coli numbering system for codons of the ribosomal protein S12 subunit was used. 
